Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mondelez International (NQ: MDLZ )

64.40 -0.39 (-0.60%)
Official Closing Price Updated: 4:15 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mondelez International

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S.... 
Via Benzinga
3 Top Consumer Staples Stocks to Buy In Q4
Consumer staples stocks aren’t having a good year after delivering record gains in 2022. Here are three to buy for a rebound in 2024. 
Via InvestorPlace
MarketBeat Week in Review – 10/16 - 10/20
All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Economy Interest Rates
What 5 Analyst Ratings Have To Say About Mondelez International
Via Benzinga
Looking Into Mondelez International's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With MDLZ
Via Benzinga
IBD's 100 Best ESG Companies For 2023
The companies on our list combine high sustainability scores and top stock ratings. 
Via Investor's Business Daily
Why Mondelez International (MDLZ) Stock Is Nosediving
MONDELEZ INTERNATIONAL INC Common Stock (NASDAQ: MDLZ) shares are trading lower by 5.6% to $61.41 Friday morning. 
Via Benzinga
Looking Into Mondelez International's Recent Short Interest
Via Benzinga
7 Dividend Stocks to Buy and Hold Forever and Ever
Investors must consider long-term dividend stocks to buy for their safety as markets remain turbulent in mid-October. 
Via InvestorPlace
Are People Done Buying Chips And Soda? Stock Market Winners And Losers From Rise Of Ozempic, Weight-Loss Drugs
With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozempic and Wegovy have gone viral on TikTok and other social platf 
Via Benzinga
Mondelez, CVS Health, Shell And A Major Retailer On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors said Mondelez International, Inc. (NASDAQ: MDLZ), has "fantastic" 
Via Benzinga
Food and Beverage Stocks Look Appetizing After Ozempic Selloff
Investors should brush off Ozempic selloff fears and dive into tasty food and beverage stocks that have been oversold in 2023. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
Via Benzinga
Snack Maker Mondelez Int'l Is Down but Not Out
If Mondelez beats consensus for Q3 and can offer reassurance about the potential impact of Ozempic, investors’ appetite for chewed up snack makers may improve. 
Via MarketBeat
Mondelēz International Celebrates 50th Anniversary of Iconic Richmond Biscuit Manufacturing Plant
From Mondelez International, Inc.
Via GlobeNewswire
Evaluating Packaged Food and Meat Sector Stocks
A discussion about the current state of the packaged food and meat sector stocks in terms of valuation. 
Via Talk Markets
Mondelēz International to Report Q3 2023 Financial Results on Nov 1, 2023
From Mondelez International, Inc.
Via GlobeNewswire
Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.
Weight-loss drugs aren't the reason for suppressed shopping cart spending in a shaky economy, Pepsi executives say. 
Via Investor's Business Daily
Topics Economy
Exposures Economy
Mondelēz International Unveils New Toblerone Brand Platform and Premium Offerings in Key Markets
From Mondelez International, Inc.
Via GlobeNewswire
Obesity Drug Boom, Split Make This Stock a Heavy Bargain
Ozempic users may be losing their appetites for sweets…but Novo Nordisk is one Danish treat that the market may only get hungrier for. 
Via MarketBeat
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior. 
Via Benzinga
Retail Resilience: 7 Consumer Goods Stocks to Buy to Weather the Storm
As market storms gather, savvy investors are seeking shelter in consumer goods stocks for their proven reliability and resilience. 
Via InvestorPlace
Big Pharma's Weight Loss Drugs Vs. Snacking Industry: Who Will Prevail?
The rising prevalence of obesity and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Ozempic is triggering concerns among investors about the future of the snacking industry.  
Via Benzinga
Mondelēz International Completes Sale Of Developed Market Gum Business to Perfetti Van Melle
From Mondelez International, Inc.
Via GlobeNewswire
3 Dividend Growth Stocks for Long-Term Returns
Dividend growth stocks can offer investors enticing long-term returns. Let's dive into three exciting options. 
Via InvestorPlace
IPO Wish List: 3 Private Companies I Really Wish Were Public
When it comes to IPOs in 2023, there haven’t been a lot of exciting companies coming to market. Here are three I’d like to see go public. 
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga
Keurig Dr Pepper Stirs Things Up: Picks Consumer Packaged Goods Veteran Tim Cofer As Next CEO
Keurig Dr Pepper Inc (NASDAQ: KDP) has appointed  
Via Benzinga
2 Reasons to Like the Smucker-Hostess Deal, One Reason to Hate It
J.M. Smucker recently announced its most significant acquisition in its history. The Smucker-Hostess deal isn’t a slam-dunk win. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.